Skip to content
Open access · CC-BY via OpenAlex

New use for an old drug: Metformin and atrial fibrillation

Manlio Vinciguerra, Iván Olier, Sandra Ortega‐Martorell, Gregory Y.H. Lip

Cell Reports Medicine · 2022 · ▲ 4 citations

Abstract

reported an integrative approach-combining transcriptomics, iPSCs, and epidemiological evidence-to identify and repurpose metformin, a main first-line medication for the treatment of type 2 diabetes, as an effective risk reducer for atrial fibrillation.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.1016/j.xcrm.2022.100875
Canonical
link ↗
Fetched
2026-10-09 MST

Cite this

APA
Vinciguerra, M., Olier, I., Ortega‐Martorell, S., &amp; Lip, G.Y. (2022). New use for an old drug: Metformin and atrial fibrillation. <em>Cell Reports Medicine</em>. https://doi.org/10.1016/j.xcrm.2022.100875
Vancouver
Vinciguerra M, Olier I, Ortega‐Martorell S, Lip GY. New use for an old drug: Metformin and atrial fibrillation. Cell Reports Medicine. 2022. doi:10.1016/j.xcrm.2022.100875.
BibTeX
@article{manlio2022Newuse, title = {New use for an old drug: Metformin and atrial fibrillation}, author = {Manlio Vinciguerra and Iván Olier and Sandra Ortega‐Martorell and Gregory Y.H. Lip}, journal = {Cell Reports Medicine}, year = {2022}, doi = {10.1016/j.xcrm.2022.100875}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings